Astria Therapeutics
Mr. Clauser has been with Catabasis for nine years, including the last three years as Vice President, Finance. He has nearly 20 years of financial experience, and served as an Accounting Manager at Impress Software before joining Catabasis.
“I am excited for this new opportunity as we approach the next stage of our company, with top-line results from the Phase 3 PolarisDMD trial for edasalonexent expected in the fourth quarter of this year,” said Mr. Clauser. “I am looking forward to continuing our work to make an impact in the lives of patients and families affected by Duchenne muscular dystrophy.”
This person is not in any offices
Astria Therapeutics
2 followers
With patients as their guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by HAE and rare and niche allergic and immunological diseases.